BiotechTube

Orgalutran

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 20/100
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fertilization in Vitro

Conditions

Fertilization in Vitro

Trial Timeline

Feb 1, 2005 → Dec 1, 2007

NCT ID
NCT01304511

About Orgalutran

Orgalutran is a pre-clinical stage product being developed by Organon for Fertilization in Vitro. The current trial status is completed. This product is registered under clinical trial identifier NCT01304511. Target conditions include Fertilization in Vitro.

What happened to similar drugs?

1 of 4 similar drugs in Fertilization in Vitro were approved

Approved (1) Terminated (1) Active (3)
✅Gonal -f® [r-hFSH] + Ovitrelle® [r-hCG alfa] + Gonadotropin-releasing hormone (GnRH) Agonist + Gonadotropin-releasing hormone (GnRH) AntagonistMerckApproved
🔄COL-1620 + Gonadotropin-releasing hormone (GnRH) analogue + Follicle-stimulating hormone (FSH) + Human Chorionic Gonadotropin (hCG)MerckPhase 3
🔄Corifollitropin alfa + RecFSH / Follitropin beta (Days 1 to 7) + Placebo Corifollitropin alfa + Placebo RecFSH / follitropin beta + RecFSH / Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPhase 3
🔄Corifollitropin alfa + FSH + GnRH antagonist + (rec)hCG + ProgesteroneOrganonPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01304511Pre-clinicalCompleted

Competing Products

9 competing products in Fertilization in Vitro

See all competitors
ProductCompanyStageHype Score
COL-1620 + Gonadotropin-releasing hormone (GnRH) analogue + Follicle-stimulating hormone (FSH) + Human Chorionic Gonadotropin (hCG)MerckPhase 3
40
Gonal -f® [r-hFSH] + Ovitrelle® [r-hCG alfa] + Gonadotropin-releasing hormone (GnRH) Agonist + Gonadotropin-releasing hormone (GnRH) AntagonistMerckApproved
35
Follitropin betaOrganonPre-clinical
20
150 µg Corifollitropin Alfa + 200 IU RecFSH/Follitropin beta (Days 1 to 7) + Placebo for Corifollitropin Alfa + Placebo for RecFSH/Follitropin beta + 200 IU RecFSH/Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPre-clinical
20
Corifollitropin alfa + RecFSH / Follitropin beta (Days 1 to 7) + Placebo Corifollitropin alfa + Placebo RecFSH / follitropin beta + RecFSH / Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPhase 3
34
corifollitropin alfa + recFSH (follitropin alfa) + gonadatropin releasing hormone (GnRH) antagonist ganirelix + human chorion gonadatropin (hCG) + progesterone + placebo-recFSH (follitropin alfa) + placebo-corifollitropin alfa + open-label recFSHOrganonPre-clinical
20
corifollitropin alfa + Follitropin beta injectionOrganonPhase 2
29
Org 36286 (corifollitropin alfa)OrganonPhase 2
29
Corifollitropin alfa + FSH + GnRH antagonist + (rec)hCG + ProgesteroneOrganonPhase 3
34